✦ LIBER ✦

When to initiate and discontinue biologic treatments for rheumatoid arthritis?

✍ Scribed by K. Chatzidionysiou; R. F. van Vollenhoven

Book ID: 108863875
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 451 KB
Volume: 269
Category: Article
ISSN: 0954-6820
DOI: 10.1111/j.1365-2796.2011.02355.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of medicare part D on access to a

Impact of medicare part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis

✍ Polinski, Jennifer M. ;Mohr, Penny E. ;Johnson, Lorraine 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB 👁 1 views

Etanercept and adalimumab treatment in p

Etanercept and adalimumab treatment in patients with rheumatoid arthritis and spondyloarthropathies in clinical practice: adverse events and other reasons leading to discontinuation of the treatment

✍ Tiina Levälampi; Markku Korpela; Katriina Vuolteenaho; Eeva Moilanen 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 341 KB

Cost-effectiveness modeling of abatacept

Cost-effectiveness modeling of abatacept versus other biologic agents in DMARDS and anti-TNF inadequate responders for the management of moderate to severe rheumatoid arthritis

✍ Anthony Russell; Ariel Beresniak; Louis Bessette; Boulos Haraoui; Proton Rahman; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 183 KB

No evidence of association between anti–

No evidence of association between anti–tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register

✍ Mark Lunt; Kath D. Watson; William G. Dixon; British Society for Rheumatology Bi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

## Objective To study the association between anti–tumor necrosis factor (anti-TNF) therapy and mortality in a national cohort of patients with rheumatoid arthritis. ## Methods We prospectively followed up 12,672 patients who were beginning anti-TNF therapy and 3,522 biologic-naive patients recei

An open-label pilot study of the effecti

An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status

✍ Arie E. van der Bijl; Ferdinand C. Breedveld; Christian E. Antoni; Joachim R. Ka 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 182 KB